Tech
Pharmeasy founder Siddharth Shah steps down as CEO
[ad_1]
Rahul Guha, the CEO of Thyrocare, will succeed Shah as the Pharmeasy CEO. API Holdings had acquired a 66.1% stake in Thyrocare for Rs 4,546 crore in June 2021. Thyrocare is listed in the public markets, while Pharmeasy is yet to float an initial public offering.
” The board of directors of API Holdings Limited… has approved the additional responsibility…
[ad_2]
Source link

You must be logged in to post a comment Login